The Bioprocess Validation Market was valued at USD 431.57 million in 2023 and is projected to reach USD 953.78 million by 2032, registering an impressive CAGR of 9.25% over the forecast period from 2024 to 2032. The market’s expansion is driven by the increasing adoption of biopharmaceuticals, rising regulatory scrutiny, and advancements in...